Special Subpopulations Archives - The NASH Podcast - Surfing the NASH Tsunami Podcast

S4-40 – Review of Paris NASH 2023

Surfing NASH returns to its regular podcast schedule with a review of the recently concluded Paris NASH meeting. Presenters and KOLs Scott Friedman and Laurent Castera join Jörn Schattenberg, Louise Campbell and Roger Green for an exciting episode that focuses largely on important and emerging questions surrounding the use of NITs in a landscape which features drug approval. Surf on to learn much more from what always pans out to be an incredibly in-depth and insightful event.

September 13, 2023

S4-26.3 – FibroScan and the Impact of Socioeconomic Factors on Liver Health

The podcast celebrates and reflects on International #NASHDay 2023 with a panel of patient advocates (Michael Betel, Gina Villiotti Madison and Marko Korenjak) and co-hosts Louise Campbell and Roger Green. This conversation offers observations around the new NICE guidance that supports FibroScan use in primary care settings. The group ventures on to discuss the effects of socioeconomic status on access to improved liver health.

June 12, 2023

S4-26.2 – The Rise of NAFLD/NASH in Adolescents

The podcast celebrates and reflects on International #NASHDay 2023 with a panel of patient advocates (Michael Betel, Gina Villiotti Madison and Marko Korenjak) and co-hosts Louise Campbell and Roger Green. This conversation focuses on the increasing incidence of NAFLD/NASH among adolescents. The group explores ideas around why this is happening and what to do about it.

June 12, 2023

S4-26.1 – What Patient Advocate Organizations Are Doing Around the World in Support of #NASHDay 2023

The podcast celebrates and reflects on International #NASHDay 2023 with a panel of patient advocates (Michael Betel, Gina Villiotti Madison and Marko Korenjak) and co-hosts Louise Campbell and Roger Green. This conversation reviews the unique ways different organizations from across the world have interacted with and shown support for #NASHDay 2023.

June 12, 2023

S4-25.5 – Wrap-Up on NICE Guidance for FibroScan

William Alazawi and Vanessa Hebditch join Louise Campbell and Roger Green to celebrate and comment on evidence-based guidance from NICE on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care in the UK. This final conversation addresses a closing question around the future of FibroScan and how NICE will have progressed on the issue over the next 18 months.

June 12, 2023

S4-25.4 – NICE Guidance for FibroScan: The Devil is in the Details

William Alazawi and Vanessa Hebditch join Louise Campbell and Roger Green to celebrate and comment on evidence-based guidance from NICE on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care in the UK. This conversation offers stimulating ideas around best ways to implement community screening.

June 12, 2023

S4-E25.1 – Meeting Vanessa Hebditch and the Role of the British Liver Trust in Fighting for FibroScan

William Alazawi and Vanessa Hebditch join Louise Campbell and Roger Green to celebrate and comment on evidence-based guidance from NICE on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care in the UK. This conversation focuses on the role of the British Liver Trust in this process and the importance of data collection for quality assurance.

June 12, 2023

S4-26 – Patient Advocate Focus on International #NASHDay 2023

The episode celebrates and reflects on International #NASHDay 2023 with a panel of patient advocates (Michael Betel, Gina Villiotti Madison and Marko Korenjak) and co-hosts Louise Campbell and Roger Green. Each speaks to what the day means to them and the group explores how the community is taking action to step up to a public health epidemic.

June 9, 2023

S4-21.3 – Curating the EASL Congress 2023 Program and 3 “Can’t Miss” Features

Aleksander Krag and Sven Francque join the Surfers to discuss the upcoming EASL Congress taking place from June 21-24 in Vienna. The group explores 3 “can’t miss” features for different participating parties and how the program was put together.

May 20, 2023

S4-21.2 – Previewing EASL Congress 2023: Highlighting Exciting Elements

Aleksander Krag and Sven Francque join the Surfers to discuss the upcoming EASL Congress taking place from June 21-24 in Vienna. The group glances at their topline anticipations of the event and share exciting elements that the audience won’t want to miss.

May 20, 2023

Category: Special Subpopulations

All Podcast Categories

S4-40 – Review of Paris NASH 2023

S4-26.3 – FibroScan and the Impact of Socioeconomic Factors on Liver Health

S4-26.2 – The Rise of NAFLD/NASH in Adolescents

S4-26.1 – What Patient Advocate Organizations Are Doing Around the World in Support of #NASHDay 2023

S4-25.5 – Wrap-Up on NICE Guidance for FibroScan

S4-25.4 – NICE Guidance for FibroScan: The Devil is in the Details

S4-E25.1 – Meeting Vanessa Hebditch and the Role of the British Liver Trust in Fighting for FibroScan

S4-26 – Patient Advocate Focus on International #NASHDay 2023

S4-21.3 – Curating the EASL Congress 2023 Program and 3 “Can’t Miss” Features

S4-21.2 – Previewing EASL Congress 2023: Highlighting Exciting Elements

Listen Now

S4-40.5 – Paris NASH Review: More Topics and Final Thoughts

S4-40.4 – Challenges in Treating and Assessing Adequately

S4-40.3 – Which test is best for which patients?

S4-40.2 – Deeper Dive into the Landscape of NITs

S4-40.1 – Liver as a Regenerative Organ and the Use and Limitations of NITs

S4-40 – Review of Paris NASH 2023

S4-39.4 – MASEF: Where will we be in 2 years?

S4-39.3 – MASEF: Next Steps and New Cohorts

S4-39.2 – MASEF: Cost Effectiveness and Application Settings

S4-39.1 – MASEF: Study Parameters and Notable Results

Experience Nudge Learning! Interested in a new way of learning?